Novartis AG Common Stock · Total Current Liabilities

Latest reported$27.28Bperiod endingDec 31, 2025

NVS FY Current Liabilities ($10.55B → $27.28B)

Annual total current liabilities

High-resolution chart · PNG

NVS total current liabilities history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Total Current Liabilities — Annual fiscal periods (USD)
Period ending	Total Current Liabilities (USD)
Dec 31, 2025	27,278,047,000
Dec 31, 2024	28,692,000,000
Dec 31, 2023	26,390,000,000
Dec 31, 2022	28,656,000,000
Dec 31, 2021	30,208,000,000
Dec 31, 2020	33,059,000,000
Dec 31, 2019	28,263,877,842
Dec 31, 2018	29,607,000,000
Dec 31, 2017	23,403,000,000
Dec 31, 2016	22,209,000,000
Dec 31, 2015	23,708,000,000
Dec 31, 2014	26,973,000,000
Dec 31, 2013	26,368,000,000
Dec 31, 2012	24,051,000,000
Dec 31, 2011	23,148,000,000
Dec 31, 2010	24,658,000,000
Dec 31, 2009	19,470,000,000
Dec 31, 2008	16,504,000,000
Dec 31, 2007	16,641,000,000
Dec 31, 2006	16,234,000,000
Dec 31, 2005	15,328,000,000
Dec 31, 2004	11,078,000,000
Dec 31, 2003	9,320,000,000
Dec 31, 2002	8,294,000,000
Dec 31, 2001	8,587,000,000
Dec 31, 2000	7,097,000,000
Dec 31, 1999	10,952,000,000
Dec 31, 1998	10,547,238,372